GlassScriptPhysician profile
Brandon P Chambers
NPI 1174020770
$11,730.78
in general payments reported to CMS, 2019-2025
31 companies · $258 in 2025
The $258 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,151 · 2022: $2,221 · 2023: $4,812 · 2024: $2,289 · 2025: $258.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,781 · Travel and Lodging: $1,493 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,781.10 |
| Travel and Lodging | $1,492.59 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $2,365.32 | 2021-2024 | Trelegy Ellipta, Nucala, Arexvy |
| Inspire Medical Systems, INC. | $2,092.77 | 2023-2025 | Inspire |
| Astrazeneca Pharmaceuticals LP | $1,186.24 | 2021-2024 | Airsupra, Breztri, Fasenra |
| Boehringer Ingelheim Pharmaceuticals, INC. | $961.16 | 2021-2024 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Actelion Pharmaceuticals US, INC. | $940.29 | 2021-2024 | Uptravi, Opsumit |
| 3b Medical, INC. | $929.83 | 2023-2025 | Luna |
| Genzyme Corporation | $544.97 | 2021-2024 | |
| Mylan Specialty L.P. | $393.49 | 2021-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $373.21 | 2021-2024 | Glassia |
| Regeneron Healthcare Solutions, INC. | $328.72 | 2021-2024 | Dupixent |
| Bayer Healthcare Pharmaceuticals INC. | $276.75 | 2021-2022 | |
| Genentech USA, INC. | $189.84 | 2021-2023 | Xolair |
| Mallinckrodt Hospital Products INC. | $169.78 | 2021-2024 | Acthar |
| Electromed, INC. | $148.73 | 2024-2025 | Smartvest |
| United Therapeutics Corporation | $143.09 | 2022-2023 | Tyvaso |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $128.24 | 2021 | |
| Insmed, INC. | $103.32 | 2022-2023 | Arikayce |
| Sanofi-Aventis U.S. LLC | $84.99 | 2024 | |
| Merck Sharp & Dohme LLC | $66.16 | 2022-2024 | Zerbaxa |
| Baxter Healthcare | $46.53 | 2022-2023 | Hillrom - Life 2000 Ventilation System |
| Pulmonx Corporation | $40.49 | 2022 | |
| Inari Medical, INC. | $33.85 | 2021-2022 | |
| Abbvie INC. | $30.09 | 2021-2022 | |
| Gilead Sciences, INC. | $25.48 | 2023 | |
| Vanda Pharmaceuticals INC. | $22.53 | 2021 | |
| Avanos Medical | $21.61 | 2024 | On-Q* Pump and Accessories |
| Philips North America LLC | $20.34 | 2021 | |
| Ambu INC. | $19.93 | 2022 | |
| Boston Scientific Corporation | $16.57 | 2021 | |
| Amgen INC. | $13.65 | 2023 | Tezspire |
| Advanced Respiratory, INC | $12.81 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandon Chambers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.